Phenotypic Analysis of HIV-1 Genotypic Drug-Resistant Isolates from China, Using a Single-Cycle System
- PDF / 173,394 Bytes
- 9 Pages / 612.28 x 790.87 pts Page_size
- 11 Downloads / 170 Views
ORIGINAL RESEARCH ARTICLE
ยช 2011 Adis Data Information BV. All rights reserved.
Phenotypic Analysis of HIV-1 Genotypic Drug-Resistant Isolates from China, Using a Single-Cycle System Zheng Jia,1,2 Sihong Xu,2 Jianhui Nie,2 Jingyun Li,3 Ping Zhong,4 Wenbo Wang2 and Youchun Wang1,2 1 2 3 4
Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, P.R. China Department of Cell Biology, National Institutes for Food and Drug Control, Beijing, P.R. China Center of AIDS, Institute of Microbiology and Epidemiology, Academy of Military Medical Science, Beijing, P.R. China Shanghai Center of Disease Control, Shanghai, P.R. China
Abstract
Background and Objectives: Drug resistance in HIV-1 is one of the main causes of failure of antiretroviral therapy. Phenotypic detection of drug-resistant HIV-1 can provide guidance in selecting the optimal treatment regimen. Traditional phenotype assays are labor intensive and time consuming. Thus, a rapid and convenient phenotype assay with a single cycle of replication was developed and used in this study. using Methods: Two restriction endonuclease sites, ApaI and AgeI, were inserted into the plasmid pSG3Denv , site-directed mutagenesis. The reverse transcriptase and protease genes of HIV-1 were amplified from patients and cloned into the modified pSG3Denv. Sixteen original recombinant pseudoviruses were generated. The phenotypic susceptibility of these 16 recombinant pseudoviruses to 12 antiretroviral drugs was determined using a luciferase reporter system, and the phenotype and genotype results were compared. Results: A modified phenotype assay with a single-cycle system was established, and its reproducibility and feasibility were validated. Approximately 89% of the phenotype results were in agreement with the genotype results; this slight disagreement may have been due to complex and multiple resistance mutations. The phenotype results showed that individual pseudoviruses with four thymidine analog mutations (TAMs) [M41L, T67N, L210W, and T215Y] in combination with various other mutations had different levels of resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Mutations E44A, T69D, and V118I influenced the pattern of resistance of TAMs. The level of resistance to non-NRTIs (NNRTIs) was also variable when different NNRTI-resistance mutations were combined. Conclusion: The single-cycle pseudovirus phenotypic susceptibility detection system reflects HIV-1 drug resistance, especially for complex resistance mutants, and could be used to screen new antiretroviral candidates.
Introduction A number of antiretroviral drugs have been approved for use in the treatment of human immunodeficiency virus (HIV) infection. Combined use of these drugs has substantially improved the clinical management of HIV-1 infection in terms of delaying disease progression, prolonging survival, and improving quality of life. However, despite this rapid progress, combination antiretroviral therapy still fails to achieve its ultimate goal in a significant proportion of patie
Data Loading...
